Torisel Kit
$842,02
$656,78
The Torisel Kit is an injectable medication specifically designed for the treatment of advanced kidney cancer, known as renal cell carcinoma, in patients exhibiting at least three out of six recognized prognostic risk factors. Additionally, it serves as a therapeutic option for adults suffering from relapsed or refractory mantle cell lymphoma (MCL). This treatment operates by inhibiting the activity of certain abnormal proteins that contribute to the proliferation of cancer cells, effectively slowing tumor growth and progression. It’s essential for patients to be aware of potential side effects, which may include fatigue, nausea, or risk of infections due to its impact on the immune system. Regular monitoring by healthcare professionals is recommended to manage these risks effectively. Patients should also discuss their full medical history with their doctor prior to starting treatment to ensure that Torisel Kit is appropriate for their condition. Overall, Torisel Kit offers hope for those battling aggressive forms of cancer by targeting the underlying mechanisms that drive tumor development.
數量
Active Pharmaceutical Ingredient
Uses
• Torisel kit is primarily used in the treatment of renal cell carcinoma (RCC), a type of kidney cancer. It targets specific pathways that promote tumor growth, helping to slow disease progression. Patients with advanced RCC may benefit from Torisel kit as part of their therapeutic regimen. Its effectiveness in managing this cancer type makes it a valuable option for oncologists.
• Another important use of Torisel kit is in the management of mantle cell lymphoma (MCL). This aggressive form of non-Hodgkin lymphoma can be challenging to treat, and Torisel kit provides a targeted approach. By inhibiting certain cellular processes, it helps control the spread of cancer cells in patients with MCL. Oncologists may consider Torisel kit for patients who require additional treatment options.
• In addition to its primary indications, Torisel kit may be utilized in clinical settings to help manage other related conditions in oncology. Its mechanism of action offers potential benefits for patients with tumors that express specific markers. Oncologists may explore the use of Torisel kit in combination therapies to enhance patient outcomes. This versatility makes it an important tool in cancer treatment strategies.
• Torisel kit is often integrated into treatment plans for patients undergoing therapy for advanced cancers. Its role in providing targeted therapy helps improve overall patient management. Physicians may prescribe Torisel kit based on individual patient needs and tumor characteristics. This personalized approach is essential in oncology, where each patient's response can vary significantly.
Benefits
Renal cell carcinoma (RCC): Renal cell carcinoma (RCC) is the most common adult kidney cancer. It starts in the cells that line the small tubes (tubules) of the kidney. Torisel Kit works by inhibiting mTOR, which slows down the growth and division of cancer cells. Mantle cell lymphoma (MCL): Mantle cell lymphoma (MCL) is a type of non-Hodgkin's lymphoma, a cancer that originates in the lymphatic system. Specifically, MCL is characterised by the abnormal proliferation of B cells in the lymph nodes, spleen, bone marrow and other organs. Torisel Kit Injection works by blocking this pathway, thereby slowing or stopping the growth of cancer cells.
Side Effects
Like all medicines, Torisel Kit may cause side effects which do not require medical attention and which will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Most Common Side Effects
• Nausea
• Edema
• High levels of Glucose
• Increase of lipid level in the blood
• Appetite Loss
• Weakness
• Rashes
• Pain in the abdomen
Common Side Effects
• Increased level of white blood cell
• Anaemia
• High levels of alkaline phosphate in the blood
• Edema
How To Use
Torisel Kit is given by a nurse or a doctor in a clinic or hospital. You should not take the drug by yourself.
Safety Advice
• Alcohol: Drinking alcohol while taking Torisel Kit Injection is generally not recommended. It may increase the risk of liver damage and it is best to avoid alcohol or to limit the amount of alcohol you drink while you are taking this medicine.
• Kidney: Torisel Kit should be used with caution in patients with severe kidney impairment. No dose adjustment is recommended in patients with mild to moderate impairment.
• Breastfeeding: There are no data on the presence of Torisel Kit Injection or its metabolites in human milk or effects on nursing infants or lactation. Because of the potential for serious adverse reactions in nursing infants, women should be advised not to breastfeed during treatment with Torisel Kit Injection and for 2 weeks after the last dose.
• Liver: For patients with mild liver disease, Torisel Kit is recommended. No dose adjustment is required in patients with mild liver impairment. However, Torisel Kit Injection is not recommended for use in patients with moderate or severe liver disease.
• Pregnancy: The use of Torisel Kit is not recommended in pregnant women as it may cause harm to the foetus if administered to a pregnant woman.
• Driving: Torisel Kit does not alter or impair the ability to drive or use machines.